批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/12/28 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/07/17 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;20MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022100 |
001 |
NDA |
AZOR |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
Yes |
No |
AB |
2007/09/26
|
COSETTE |
206884 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2016/10/26
|
MACLEODS PHARMS LTD |
207216 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2016/10/28
|
AJANTA PHARMA LTD |
202933 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Discontinued |
No |
No |
AB |
2016/11/25
|
TORRENT |
206906 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/05/15
|
AUROBINDO PHARMA |
207807 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Discontinued |
No |
No |
AB |
2017/07/05
|
GLENMARK PHARMS LTD |
207073 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/07/17
|
ALEMBIC |
209042 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/08/14
|
ALKEM LABS LTD |
207771 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/09/22
|
ZYDUS PHARMS |
207435 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/11/02
|
MICRO LABS |
209010 |
001 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;20MG |
Prescription |
No |
No |
AB |
2018/12/03
|
SCIEGEN PHARMS INC |
活性成分:AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;40MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022100 |
002 |
NDA |
AZOR |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
Yes |
No |
AB |
2007/09/26
|
COSETTE |
206884 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2016/10/26
|
MACLEODS PHARMS LTD |
207216 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2016/10/28
|
AJANTA PHARMA LTD |
202933 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Discontinued |
No |
No |
AB |
2016/11/25
|
TORRENT |
206906 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/05/15
|
AUROBINDO PHARMA |
207807 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Discontinued |
No |
No |
AB |
2017/07/05
|
GLENMARK PHARMS LTD |
207073 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/07/17
|
ALEMBIC |
209042 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/08/14
|
ALKEM LABS LTD |
207771 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/09/22
|
ZYDUS PHARMS |
207435 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/11/02
|
MICRO LABS |
209010 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 5MG BASE;40MG |
Prescription |
No |
No |
AB |
2018/12/03
|
SCIEGEN PHARMS INC |
活性成分:AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;20MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022100 |
003 |
NDA |
AZOR |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
Yes |
No |
AB |
2007/09/26
|
COSETTE |
206884 |
002 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2016/10/26
|
MACLEODS PHARMS LTD |
207216 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2016/10/28
|
AJANTA PHARMA LTD |
202933 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Discontinued |
No |
No |
AB |
2016/11/25
|
TORRENT |
206906 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/05/15
|
AUROBINDO PHARMA |
207807 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Discontinued |
No |
No |
AB |
2017/07/05
|
GLENMARK PHARMS LTD |
207073 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/07/17
|
ALEMBIC |
209042 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/08/14
|
ALKEM LABS LTD |
207771 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/09/22
|
ZYDUS PHARMS |
207435 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2017/11/02
|
MICRO LABS |
209010 |
003 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;20MG |
Prescription |
No |
No |
AB |
2018/12/03
|
SCIEGEN PHARMS INC |
活性成分:AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;40MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022100 |
004 |
NDA |
AZOR |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
Yes |
Yes |
AB |
2007/09/26
|
COSETTE |
206884 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2016/10/26
|
MACLEODS PHARMS LTD |
207216 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2016/10/28
|
AJANTA PHARMA LTD |
202933 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Discontinued |
No |
No |
AB |
2016/11/25
|
TORRENT |
206906 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/05/15
|
AUROBINDO PHARMA |
207807 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Discontinued |
No |
No |
AB |
2017/07/05
|
GLENMARK PHARMS LTD |
207073 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/07/17
|
ALEMBIC |
209042 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/08/14
|
ALKEM LABS LTD |
207771 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/09/22
|
ZYDUS PHARMS |
207435 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2017/11/02
|
MICRO LABS |
209010 |
004 |
ANDA |
AMLODIPINE AND OLMESARTAN MEDOXOMIL |
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL |
TABLET;ORAL |
EQ 10MG BASE;40MG |
Prescription |
No |
No |
AB |
2018/12/03
|
SCIEGEN PHARMS INC |